Rxivist logo

Sleep is bi-directionally modified by amyloid beta oligomers

By Güliz Gürel Özcan, Sumi Lim, Patricia L.A. Leighton, W. Ted Allison, Jason Rihel

Posted 16 Apr 2019
bioRxiv DOI: 10.1101/610014 (published DOI: 10.7554/eLife.53995)

Disrupted sleep is a major feature of Alzheimer's Disease (AD), often arising years before symptoms of cognitive decline. Prolonged wakefulness exacerbates the production of amyloid-beta (Aβ) species, a major driver of AD progression, suggesting that sleep loss further accelerates AD through a vicious cycle. However, the mechanisms by which Aβ affects sleep are unknown. We demonstrate in zebrafish that Aβ acutely and reversibly enhances or suppresses sleep as a function of oligomer length. Genetic disruptions revealed that short Aβ oligomers induce acute wakefulness through Adrenergic receptor b2 (Adrb2) and Progesterone membrane receptor component 1 (Pgrmc1), while longer Aβ forms induce sleep through a pharmacologically tractable Prion Protein (PrP) signalling cascade. Our data indicate that Aβ can trigger a bi-directional sleep/wake switch. Alterations to the brain's Aβ oligomeric milieu, such as during the progression of AD, may therefore disrupt sleep via changes in acute signalling events. ### Competing Interest Statement The authors have declared no competing interest.

Download data

  • Downloaded 989 times
  • Download rankings, all-time:
    • Site-wide: 30,066
    • In neuroscience: 3,791
  • Year to date:
    • Site-wide: 8,878
  • Since beginning of last month:
    • Site-wide: 68,538

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide